Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-04

AURA vs ENTX: stock comparison and AI forecast

Aura Biosciences, Inc. (AURA) and Entera Bio Ltd. (ENTX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Biological Products, (No Diagnostic Substances)

AURA Aura Biosciences, Inc.

Price
$6.24 -29.9% · 6M
Market Cap
$647M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Biological Products, (No Diagnostic Substances)

ENTX Entera Bio Ltd.

Price
$3.09 +178.4% · 6M
Market Cap
$535M
P/E Ratio
9.4x
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

6M · 2026-05-05 → 2026-11-03

Six-month price performance

Closing prices rebased to 100 at the start of the window.

65130195260325
AURA -29.9% ENTX +178.4%
AURA · ENTX

Key facts

  • AURA is 1.2 times larger than ENTX by market capitalization ($647M against $535M).
  • Over the last six months ENTX returned +178.4% and AURA -29.9%.
  • ENTX carries 1.68 times debt per unit of equity, against 0.10 times for AURA.
  • Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricAURAENTX
Market Cap$647M$535M
P/E Ratio–9.36x
P/B Ratio2.05x73.63x
EPS$-1.77$0.33
Book Value/Share$3.04$0.04
Revenue/Share–$0.00
FCF/Share$-1.00$-0.06

Profitability & Margins

MetricAURAENTX
ROE-41.6%–
ROA-37.6%–
ROIC-42.0%-82.9%
Tax Rate-0.1%–

Financial Health

MetricAURAENTX
Current Ratio16.82x8.98x
D/E Ratio0.10x1.68x
Financial Leverage1.10x2.68x
Working Capital$309M$17M

Cash Flow

MetricAURAENTX
Operating Cash Flow-$103M-$11M
Free Cash Flow-$103M-$11M
Capital Spending-$340K-$70K

Operational Efficiency

MetricAURAENTX
Asset Turnover–0.00x
Fixed Assets Turnover–0.0x

Income Statement

MetricAURAENTX
Total Revenue–$0.00M
Operating Income-$138M-$14M
Net Income-$131M–
R&D Expense$103M$9M
SG&A Expense–$550K
Cost of Goods Sold–$0.00M

Dividend & Shareholder Information

MetricAURAENTX
Shares Outstanding104M173M
EPS Growth–32.0%
FAQ

AURA vs ENTX: stock comparison and AI forecast

Which is bigger, AURA or ENTX?

AURA is 1.2 times larger than ENTX by market capitalization ($647M against $535M).

Which stock performed better over the last six months, AURA or ENTX?

Over the last six months ENTX returned +178.4% and AURA -29.9%.

Which one does Intratio's AI model rank higher, AURA or ENTX?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.